Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

Share Price is delayed by 15 minutes
Get Live Data
139.50    0.00 (0.00%)
Bid:
137.00
Ask:
142.00
Spread: 5.00 (3.65%)
Market Cap: £78.87m
MVI Live PriceLast checked at - London Stock Exchange

Intraday Marwyn Val. Share Chart

Share Acquisition

26 May 2026 16:43

RNS Number : 7636F
Marwyn Value Investors Limited
26 May 2026
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

LEI: 213800L5751QTTVEA774

26 May 2026

 

This announcement contains inside information

 

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

SHARE ACQUISITION

The Company announces that it has been notified that on 26 May 2026, Marwyn Investment Management LLP, the Manager of the Company and of Marwyn Value Investors LP (the "Master Fund"), purchased 600,000 Ordinary Shares in the Company ("Ordinary Shares") at a price of 141.00 pence per share on behalf of the Master Fund, representing approximately 1.06% of the Company's voting rights.

For the avoidance of doubt, the shares have been acquired by the Master Fund, in which the Company is an investor. The Master Fund will hold the acquired Ordinary Shares as an investment, included in its Net Asset Value calculations at the prevailing quoted price.

The Master Fund may acquire further Ordinary Shares on the same basis.

Whilst the Manager is not a Person Discharging Managerial Responsibility ("PDMR") within the meaning of the UK version of Regulation (EU) 596/2014, as incorporated in the UK by virtue of the European Union (Withdrawal) Act 2018, as amended in relation to the Company, it has voluntarily disclosed the information above to the Company, and the Company is voluntarily disclosing the information above to the market, as if it was a PDMR in relation to the Company.

This announcement contains inside information for the purposes of Article 7 of the UK version of EU Regulation 596/2014 which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"), and is disclosed in accordance with the Company's obligations under MAR. The person responsible for making this announcement is Robert Ware, Chairman, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Island.

Company enquiries:

Marwyn Value Investors Limited

Scott Danks

scottdanks@marwyn.com

 

Company Secretary - Palmer Fund Services (Jersey) Limited

marwyn@palmerfs.com

1 Grenville Street

St Helier

Jersey JE2 4UF

 

Corporate Broker - Panmure Liberum Limited

Chris Clarke

0203 100 2200

 

Shares in the Company are not designed or intended for retail investors. Marwyn Investment Management LLP, the Manager, does not promote shares in the Company to retail investors and they should not be offered to retail investors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGZKKVGGVZM
Date   Source Headline
27th Jul 20237:00 amRNSInterim Dividend to Ordinary Shareholders
21st Jul 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
21st Jul 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
21st Jul 202310:00 amRNSNet Asset Value - Ordinary Shares
14th Jul 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
14th Jul 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
14th Jul 202310:00 amRNSNet Asset Value - Ordinary Shares
7th Jul 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
7th Jul 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
7th Jul 202310:00 amRNSNet Asset Value - Ordinary Shares
30th Jun 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
30th Jun 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
30th Jun 202310:00 amRNSNet Asset Value - Ordinary Shares
23rd Jun 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
23rd Jun 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
23rd Jun 202310:00 amRNSNet Asset Value - Ordinary Shares
16th Jun 20237:00 amRNSShare Dealings
14th Jun 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
14th Jun 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
14th Jun 202310:00 amRNSNet Asset Value - Ordinary Shares
8th Jun 202310:00 amRNSAdvancedAdvT – Acquisitions
6th Jun 20237:10 amRNSAppointment of Will Self as MAC II CEO
2nd Jun 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd Jun 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd Jun 202310:00 amRNSNet Asset Value - Ordinary Shares
26th May 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
26th May 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
26th May 202310:00 amRNSNet Asset Value - Ordinary Shares
25th May 20237:00 amRNSInvestment in Palmer Street Limited
12th May 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
12th May 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
12th May 202310:00 amRNSNet Asset Value - Ordinary Shares
10th May 20238:46 amRNSUpdate in relation to Unbound Group Plc
5th May 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
5th May 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
5th May 202310:00 amRNSNet Asset Value - Ordinary Shares
28th Apr 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
28th Apr 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
28th Apr 202310:00 amRNSNet Asset Value - Ordinary Shares
28th Apr 20237:00 amRNSAnnual Financial Statements December 2022
26th Apr 20237:00 amRNSInterim Dividend to Ordinary Shareholders
18th Apr 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
18th Apr 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
18th Apr 202310:00 amRNSNet Asset Value - Ordinary Shares
12th Apr 20231:31 pmRNSUnbound Group Plc Investment Proposal
11th Apr 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
11th Apr 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
11th Apr 202310:00 amRNSNet Asset Value - Ordinary Shares
31st Mar 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
31st Mar 202310:05 amRNSNet Asset Value - 2016 Realisation Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.